We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer.
- Authors
Chung, Ki Y; Gore, Ira; Fong, Lawrence; Venook, Alan; Beck, Stephen B; Dorazio, Prudence; Criscitiello, Peggy J; Healey, Diane I; Huang, Bo; Gomez-Navarro, Jesus; Saltz, Leonard B
- Abstract
Safety and efficacy of tremelimumab (CP-675,206), a fully human anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) monoclonal antibody, were assessed in patients with treatment-refractory colorectal cancer.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Vol 28, Issue 21, p3485
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2010.28.3994